SCHEMBL29745899

SCHEMBL29745899

Cc1ccc2c(c1)NC(c1ccc(S(N)(=O)=O)cc1)CC2

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 13/20 0.44
▸ CA2 P00918 13/20 0.44
▸ CA9 Q16790 11/20 0.44
▸ CA7 P43166 9/20 0.44
▸ CA12 O43570 8/20 0.44
▸ CA3 P07451 1/20 0.44
▸ CA6 P23280 1/20 0.44
▸ CA5A P35218 1/20 0.44
▸ CA5B Q9Y2D0 1/20 0.44
▸ PTGS2 P35354 4/20 0.42
▸ PTGS1 P23219 3/20 0.42
▸ ESR1 P03372 1/20 0.42
▸ ESR2 Q92731 1/20 0.42
▸ CA14 Q9ULX7 6/20 0.39
▸ ADRA2A P08913 1/20 0.37
▸ PNMT P11086 1/20 0.37
▸ ADRA2B P18089 1/20 0.37
▸ ADRA2C P18825 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26613434 1.00 CA1 (0.44) CA1CA2CA9CA7CA12
SCHEMBL26613392 0.91 ESR1 (0.50) CA1CA2CA9CA7CA12
SCHEMBL26613422 0.84 PTGS2 (0.43) CA1CA2CA9CA7CA12
SCHEMBL29746029 0.84 PTGS2 (0.43) CA1CA2CA9CA7CA12
SCHEMBL29746019 0.82 ESR1 (0.44) CA1CA2CA9CA7CA12
SCHEMBL26613384 0.82 ESR1 (0.44) CA1CA2CA9CA7CA12
SCHEMBL29746031 0.79 ESR1 (0.45) ESR1ESR2
SCHEMBL26613374 0.79 ESR1 (0.45) ESR1ESR2
SCHEMBL26613454 0.78 ESR1 (0.50) CA1CA2CA9CA7CA12
SCHEMBL26613388 0.78 ESR1 (0.53) CA1CA2CA9CA7CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119403554-A Therapeutic or prophylactic agent for amyotrophic lateral sclerosis 东丽株式会社 2025-02-07 — — CN claimed
CN-116648245-A Tetrahydroquinoline derivative and medical application thereof 东丽株式会社 2023-08-25 — — CN claimed
WO-2022138888-A1 TETRAHYDROQUINOLINE DERIVATIVE AND MEDICINAL USE THEREOF 東レ株式会社 2022-06-30 — — WO claimed
CN-119403554-A Therapeutic or prophylactic agent for amyotrophic lateral sclerosis 东丽株式会社 2025-02-07 — — CN disclosed
CN-116648245-A Tetrahydroquinoline derivative and medical application thereof 东丽株式会社 2023-08-25 — — CN disclosed
WO-2022138888-A1 TETRAHYDROQUINOLINE DERIVATIVE AND MEDICINAL USE THEREOF 東レ株式会社 2022-06-30 — — WO disclosed
Send feedback